Documented and potential research impacts of subclinical diseases in zebrafish

ILAR Journal

Volumn 53, Issue 2, 2012, Pages 126-134

  Kent, Michael L ^a   Harper, Claudia ^b   Wolf, Jeffrey C ^c  

^a OREGON STATE UNIVERSITY   (United States)

^b Laboratory animal veterinarian   (United States)

^c EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873443589     PISSN: 10842020     EISSN: 19306180     Source Type: Journal    
DOI: 10.1093/ilar.53.2.126     Document Type: Article

References (51)

1. Abner SR, Frazier CL, Scheibe JS, Krol RA, Overstreet RM, Walker WW, Hawkins WE. 1994. Chronic inflammatory lesions in two small fish species, medaka (Oryzias latipes) and guppy (Poecilia reticulata), used in carcinogenesis bioassays. In: Stolen JS, Fletcher TC, eds. Modulators of Fish Immune Responses: Models for Environmental Toxicology, Biomarkers, and Immunostimulators. Fair Haven (NJ): SOS Publica-tions. p 219-233.
2. Andersen RJ, Luu HA, Chen DZX, Holmes CFB, Kent ML, Le Blanc M, Taylor FJR, Williams DE. 1993. Chemical and biological evidence links microcystin to salmon "netpen liver disease." Toxicon 31:1315-1323.
3. Astrofsky KM, Schrenzel MD, Bullis RA, Smolowitz RM, Fox JG. 2000. Diagnosis and management of atypical Mycobacterium spp. infections in established laboratory zebrafish (Brachydanio rerio) facilities. Comp Med 50:666-672.
4. Boersma MC, Meffert MK. 2008. Novel roles for the NF-kappaB signaling pathway in regulating neuronal function. Sci Signal 1(6):pe7.
5. Broussard GW, Norris MB, Schwindt AR, Fournie JW, Winn RN, Kent ML, Ennis DG. 2009. Chronic Mycobacterium marinum infection acts as a tu-mor promoter in Japanese medaka. Comp Biochem Physiol C Toxicol Pharmacol 149:152-160.
6. Capps T, Mukhi S, Rinchard JJ, Theodorakis CW, Blazer VS, Patino R. 2004. Exposure to perchlorate induces formation of macrophage aggregates in the trunk kidney of zebrafish and mosquito fish. J Aquat Animal Health 16:145-151.
7. Chaisson ML, Branstetter DG, Derry JM, Armstrong AP, Tometsko ME, Takeda K, Akira S, Dougall WC. 2004. Osteoclast differentiation is im-paired in the absence of inhibitor of kappa B kinase alpha. J Biol Chem 279:54841-54848.
8. Crim M, Riley LK. 2012. Viral diseases in zebrafish: What is known and unknown. ILAR J 53:135-143.
9. Didier ES. 2005. Microsporidiosis: An emerging and opportunistic infec-tion in humans and animals. Acta Tropica 94:61-76.
10. Doherty GH. 2007. Developmental switch in the effects of TNFalpha on ventral midbrain dopaminergic neurons. Neurosci Res 57:296-305.
11. Gerhard GS. 2007. Small laboratory fish as models for aging research. Age-ing Res Rev 6:64-72.
12. Ferguson J, Watral V, Schwindt A, Kent ML. 2007. Spores of two fish Microsporidia (Pseudoloma neurophilia and Glugea anomola) are highly resistant to chlorine. Dis Aquat Org 76:205-214.
13. Flegr J. 2007. Effects of Toxoplasma on human behavior. Schizophr Bull 33:757-760.
14. Fukunaga H, Murakami T, Gondo T, Sugi K, Ishihara T. 2002. Sensitivity of acid-fast staining for Mycobacterium tuberculosis in formalin-fixed tis-sue. Am J Respir Crit Care Med 166:994-997.
15. Hendricks JD, Sinnhuber RO, Henderson MC, Buhler DR. 1981. Liver and kidney pathology in rainbow trout (Salmo gairdneri) exposed to dietary pyrrolizidine (Senecio) alkaloids. Exper Mol Pathol 35:170-183.
16. Hernández-Gutierrez I, García-Peláez, Zentella-Dehesa A, Ramos-Kuri M, Hernández-Franco P, Hernández-Sánchez F, Rojas E. 2006. NF-kappaB signaling blockade by Bay 11-7085 during early cardiac morphogenesis induces alterations of the outflow tract in chicken heart. Apoptosis 11:1101-1109.
17. Hisaoka KK, Firlit CF. 1962. Ovarian cycle and egg production in the zebrafish, Brachydanio rerio. Copeia 1962:788-792.
18. Kent ML. 1990. Netpen liver disease (NLD) of salmonid fishes reared in sea water: Species susceptibility, recovery, and probable cause. Dis Aquat Org 8:21-28.
19. Kent ML, Bishop-Stewart JK, Matthews JL, Spitsbergen JM. 2002. Pseudo-capillaria tomentosa, a nematode pathogen, and associated neoplasms of zebrafish (Danio rerio) kept in research colonies. Comp Med 52: 354-588.
20. Kent ML, Matthews JL, Bishop-Stewart JK, Whipps CM, Watral V, Poort M, Bermudez LE. 2004. Mycobacteriosis in zebrafish (Danio rerio) research facilities. Comp Biochem Physiol C Toxicol Pharmacol 138:383-390.
21. Kent ML, Buchner C, Watral VG, Sanders JL, LaDu J, Peterson TS, Tanguay RL. 2011. Development and maintenance of a specific pathogen free (SPF) zebrafish research facility for Pseudoloma neurophilia. Dis Aquat Org 95:73-79.
22. Künzel F, Joachim A. 2010. Encephalitozoonosis in rabbits. Parasitol Res 106:299-309.
23. Lieschke GJ, Currie P D. 2007. Animal models of human disease: Zebrafish swim into view. Nature Rev Gen 5: 353-367.
24. Lipman NS, Perkins SE. 2002. Factors that may influence animal research. In: Fox JG, Anderson LC, Loew FM, Quimby FW, eds. Laboratory Animal Medicine, 2nd ed. Orlando (FL): Academic Press. p 1143-1184.
25. Liu S, Leach SD. 2011. Zebrafish models for cancer. Ann Rev Pathol Mech Dis 6:71-93.
26. Matthews JL, Brown AMV, Larison K, Bishop-Stewart JK, Rogers P, Kent ML. 2001. Pseudoloma neurophilia n.g., n.sp., a new genus and species of Microsporidia from the central nervous system of the zebrafish (Danio rerio). J Euk Microbiol 48:229-235
27. Mathew LK, Simonich MT, Tanguay RL. 2009. AHR-dependent misregula-tion of Wnt signaling disrupts tissue regeneration. Biochem Pharmacol 77:498-507.
28. Murray KN, Bauer J, Tallen A, Matthews JL, Westerfield M, Varga ZM. 2011. Characterization and management of asymptomatic Mycobacterium infections at the Zebrafish International Resource Center. JAALAS 50:675-679.
29. Murray KN, Dreska M, Nasiadka A, Rinne M, Matthews JL, Carmichael C, Bauer J, Varga ZM, Westerfield M. 2011. Transmission, diagnosis, and recommendations for control of Pseudoloma neurophilia infections in laboratory zebrafish (Danio rerio) facilities. Comp Med 61:322-329.
30. Myers MS., Johnson LL, Collier TK. 2003. Establishing the causal relation-ship between polycyclic aromatic hydrocarbon (PAH) exposure and he-patic neoplasms and neoplasia-related liver lesions in English sole (Pleuronectes vetulus) Human Ecol Risk Assess 9:67-94.
31. Peterson TS, Spitsbergen JM, Feist SW, Kent ML. 2011. The Luna stain, an improved selective stain for detection of microsporidian spores in histo-logic sections. Dis Aquat Org 95:175-180.
32. Petrie-Hanson L, Romano CL, Mackey RB, Khosravi P, Hohn CM, Boyle CR. 2007. Evaluation of zebrafish Danio rerio as a model for enteric septicemia of catfish (ESC). J Aquat Anim Health 19:151-158.
33. Phelps HA, Neely MN. 2005. Evolution of the zebrafish model: From devel-opment to immunity and infectious disease. Zebrafish 2:87-103.
34. Prouty MG, Correa NE, Barker LP, Jagadeeswaran P, Klose KE. 2003. Zebrafish-Mycobacterium marinum model for mycobacterial patho-genesis. FEMS 225:177-182.
35. Ramsay JM, Watral V, Schreck CB, Kent ML. 2009a. Husbandry stress ex-acerbates mycobacterial infections in adult zebrafish, Danio rerio (Hamilton). J Fish Dis 32:931-941.
36. Ramsay JM, Watral V, Schreck CB, Kent ML. 2009b. Pseudoloma neuro-philia (Microsporidia) infections in zebrafish (Danio rerio): Effects of stress on survival, growth and reproduction. Dis Aquat Org 88:69-84.
37. Rossteuscher S, Schmidt-Posthaus H, Schäfers C, Teigeler T, Segner H. 2008. Background pathology of the ovary in a laboratory population of zebrafish Danio rerio. Dis Aquat Org 79:169-172.
38. Sanders JL, Watral V, Kent ML. 2012. Microsporidiosis in zebrafish re-search facilities. ILAR J 53:106-113.
39. Scholz S, Mayer I. 2008. Molecular biomarkers of endocrine disruption in small model fish. Mol Cell Endocrinol 293:57-70.
40. Segner H. 2009. Zebrafish (Danio rerio) as a model organism for investigat-ing endocrine disruption. Comp Biochem Physiol C Toxicol Pharmacol 149:187-195
41. Sisson M, Cawker J, Buske C, Gerlai R. 2006. Fishing for genes of verte-brate behavior: Zebra fish as an upcoming model system. Lab Anim 35:33-39.
42. Skinner AMJ, Watt PJ. 2007. Strategic egg allocation in the zebra fish, Danio rerio. Behav Ecol 18:905-909.
43. Spitsbergen JM, Buhler DR, Peterson TL. 2012. Neoplasia and neoplasm-associated lesions in laboratory colonies of zebrafish emphasizing key influences of diet and aquaculture system design. ILAR J 53: 114-125.
44. Spitsbergen JM, Kent ML. 2003. The state of the art of the zebrafish model for toxicology and toxicologic pathology research: Advantages and cur-rent limitations. Toxicol Pathol 31(suppl):62-87.
45. Traver DA, Winzeler HM, Stern EA, Mayhall DM, Langenau JL, Kutok AT Look, Zon LI. 2004. Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation. Blood 104:1298-1305.
46. Trede NS, Langenau M, Traver D, Look AT, Zon LI. 2004. The use of zebrafish to understand immunity. Immunity 20:367-379.
47. Truong L, Harper SL, Tanguay RL. 2011. Evaluation of embryotoxicity using the zebrafish model. Methods Mol Biol 691:271-279.
48. Watral V, Kent ML. 2007. Pathogenesis of Mycobacterium spp. in zebrafish (Danio rerio) from research facilities. Comp Biochem Physiol C Toxicol Pharmacol 145:55-60.
49. Whipps CM, Dougan ST, Kent ML. 2007. Mycobacterium haemophilum infections of zebrafish (Danio rerio) in research facilities. FEMS Mi-crobiol Lett 270:21-26.
50. Whipps CM, Lieggi C, Wagner R. 2012. Mycobacteriosis in zebrafish colo-nies. ILAR J 53:95-105.
51. Whipps CM, Matthews JL, Kent ML. 2008. Distribution and genetic char-acterization of Mycobacterium chelonae in laboratory zebrafish (Danio rerio). Dis Aquat Org 82:45-54.